{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:23:53Z","timestamp":1791397433623,"version":"4.3.3"},"reference-count":48,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2010,2,22]],"date-time":"2010-02-22T00:00:00Z","timestamp":1266796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathology International"],"published-print":{"date-parts":[[2010,4]]},"abstract":"<jats:p>Angioimmunoblastic T\u2010cell lymphoma (AITL) is a peripheral T\u2010cell lymphoma characterized by systemic disease with polymorphous infiltrate including macrophages. Although many studies of tumor\u2010associated macrophage (TAM) populations in various malignant tumors have been published, only a few have dealt with activation of macrophage phenotypes such as M1 and M2 in tumor tissue. Because M2 macrophages highly express CD163, we suspected that CD163 may be a useful marker for identification of activation of macrophage phenotypes in AITL. We performed a retrospective study of immunohistochemical expression using two markers for macrophages [CD68 (PG\u2010M1), CD163] and of the correlation of these expressions with overall survival of 42 AITL patients. The number of CD68\u2010positive cells in AITL tissues did not correlate with overall survival (<jats:italic>P<\/jats:italic>= 0.59), whereas the number of CD163\u2010positive cells and overall survival correlated to some extent (<jats:italic>P<\/jats:italic>= 0.08). Meanwhile, a higher ratio of CD163\u2010positive to CD68\u2010positive cells in AITL significantly correlated with worse overall survival (<jats:italic>P<\/jats:italic>= 0.036). Considering that this ratio reflects the proportion of macrophages polarized to the M2 phenotype, our findings indicate that activation of macrophages towards the M2 phenotype correlates with worse prognosis. Our findings indicate that the ratio of M2 macrophages expressed may be a useful marker for prognosis of AITL.<\/jats:p>","DOI":"10.1111\/j.1440-1827.2010.02514.x","type":"journal-article","created":{"date-parts":[[2010,2,22]],"date-time":"2010-02-22T10:59:45Z","timestamp":1266836385000},"page":"278-283","source":"Crossref","is-referenced-by-count":113,"title":["Ratio of M2 macrophage expression is closely associated with poor prognosis for Angioimmunoblastic T\u2010cell lymphoma (AITL)"],"prefix":"10.1111","volume":"60","author":[{"given":"Daisuke","family":"Niino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Komohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshizo","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Hashikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Kiyasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuko","family":"Suefuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Sugita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"Takeya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,3,17]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1256"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4906(02)02302-5"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910500104"},{"key":"e_1_2_6_5_2","first-page":"425","article-title":"Macrophage infiltration and its prognostic implications in breast cancer: The relationship with VEGF expression and microvessel density","volume":"14","author":"Tsutsui S","year":"2005","journal-title":"Oncol Rep"},{"key":"e_1_2_6_6_2","first-page":"5857","article-title":"Reduced infiltration of tumor\u2010associated macrophages in human prostate cancer: Association with cancer progression","volume":"60","author":"Shimura S","year":"2000","journal-title":"Cancer Res"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1159\/000281194"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-2073"},{"key":"e_1_2_6_9_2","first-page":"5015","article-title":"The degree of macrophage infiltration into the cancer cell nest is a significant predictor of survival in gastric cancer patients","volume":"23","author":"Ohno S","year":"2003","journal-title":"Anticancer Res"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-04-1565"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.2008.02268.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri978"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0602325"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2004.09.015"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80014-X"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.10.7303"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1369\/jhc.5A6871.2006"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.67.1.97"},{"key":"e_1_2_6_19_2","first-page":"76","article-title":"Prognostic significance of T\u2010cell phenotype in aggressive non\u2010Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA)","volume":"92","author":"Gisselbrecht C","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008418727472"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdf033"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(74)90553-4"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1985.tb02819.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.1993.tb00491.x"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.5.1361.1361"},{"key":"e_1_2_6_26_2","first-page":"569","volume-title":"Neoplastic Hematopathology","author":"Frizzera G","year":"2001"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197802)41:2<578::AID-CNCR2820410226>3.0.CO;2-8"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19830715)52:2<318::AID-CNCR2820520221>3.0.CO;2-G"},{"key":"e_1_2_6_29_2","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/BF00195772","article-title":"Angioimmunoblastic lymphadenopathy type of T\u2010cell lymphoma and angioimmunoblastic lymphadenopathy: A clinicopathological and molecular biological study of 13 Chinese patients using polymerase chain reaction and paraffin\u2010embedded tissues","volume":"424","author":"Lorenzen J","year":"1994","journal-title":"Virchows Arch"},{"key":"e_1_2_6_30_2","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow SH","year":"2008"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1309\/QHD6YFN81KQXUUH6"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000157940.80538.ec"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V81.6.1607.1607"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri1733"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2006.01.003"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1027"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-4005"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.2370"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200113903"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1003523"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200737042"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.8.5023"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19990702)82:1<12::AID-IJC3>3.0.CO;2-O"},{"key":"e_1_2_6_44_2","first-page":"4281","article-title":"Clinical effects of tumor\u2010associated macrophages and dendritic cells on renal cell carcinoma","volume":"22","author":"Hamada I","year":"2002","journal-title":"Anticancer Res"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-2042.2000.00190.x"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690158"},{"key":"e_1_2_6_47_2","first-page":"445","article-title":"Tumor associated macrophages in human prostate cancer: Relation to clinicopathological variables and survival","volume":"17","author":"Lissbrant IF","year":"2000","journal-title":"Int J Oncol"},{"key":"e_1_2_6_48_2","first-page":"3335","article-title":"Correlation of histological localization of tumor\u2010associated macrophages with clinicopathological features in endometrial cancer","volume":"24","author":"Ohno S","year":"2004","journal-title":"Anticancer Res"},{"key":"e_1_2_6_49_2","first-page":"1414","article-title":"Tumor\u2010infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma","volume":"42","author":"Makitie T","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Pathology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1827.2010.02514.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1827.2010.02514.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T05:48:35Z","timestamp":1697262515000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1827.2010.02514.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,17]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["10.1111\/j.1440-1827.2010.02514.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1827.2010.02514.x","archive":["Portico"],"relation":{},"ISSN":["1320-5463","1440-1827"],"issn-type":[{"value":"1320-5463","type":"print"},{"value":"1440-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,17]]}}}